Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
Revolutionary, micro-invasive, injectable treatment for the full range of glaucoma disease severity iDose TR was designed to usher in a new era of interventional glaucoma by enabling a proactive...